Transgenic mice expressing human α-synuclein variants (A53T, A30P, E46K) develop progressive motor deficits, synaptic dysfunction, and intracellular aggregates reminiscent of PD pathology [158,159,160]. This evidence concerns the gene SNCA and Parkinson disease.